The reduction in IL-4 levels after treatment mirrors the pattern seen in obesity, where individuals with obesity and IR exhibit significantly lower IL-4 levels in both adipose tissue and plasma compared to lean individuals. Here, IL4 is linked to obesity due to melanocortin 4 receptor deficiency.